CPA is now offering online homestudy opportunities for pharmacists and pharmacy technicians! Check out the knowledge-based, one-hour recorded programs below, which are free for all CPA members and $9.99 for non-members. The process for receiving credit for the homestudy is two-fold. First, register as a member or non-member. Second, watch the video in full, and complete the online evaluation. All participants must pass the evaluation with a grade of 70 percent or higher. Once the evaluation is completed, credits will be uploaded within a month. The date that participants submit the evaluation will be the date recorded in their NABP e-profile. Here are the following programs that CPA currently offers.
The Pressure is On | 2017 Guidelines for the Management of High Blood Pressure in Adults
Presented by Courtney Doyle-Campbell, PharmD, of Western New England University/RiverBend HTN Clinic.
This program is provided by CPA and the Massachusetts Pharmacists Association and accredited by CPA.
In order to complete this program, you must
- Review the program objectives
- Register online (below)
- View the presentation (you will receive an email with the link and instructions)
- Complete and submit the evaluation form (also in the email)
Please register below. Once you have registered, you will receive an email with instructions on accessing the video and completing the evaluation form.
Looking Ahead | The Future of EPCS and Opioid Law
Presented by Rod Marriott, PharmD, the director of Drug Control for the CT Department of Consumer Protection.
Participants will receive 0.1 Law CEUs for this program. If you missed out on this program on December 8, 2017, now is your chance to get up to speed on the e-prescribing process.
Shifting Paradigms | The Evolution of Psoriasis from Ancient Plague to Modern Archetype
Presented by Sam Awan, MD, Chief Resident in Dermatology at UConn Health Center, Farmington, CT.
This presentation was recorded at CPA’s 2018 Mid-Winter Conference on February 1, 2018 and was supported by a grant from Celgene Corporation.